The Ramco Cements Limited (NSE:RAMCOCEM)
India flag India · Delayed Price · Currency is INR
1,151.10
-26.10 (-2.22%)
Aug 1, 2025, 3:30 PM IST

Intra-Cellular Therapies Revenue

In the fiscal year ending March 31, 2025, The Ramco Cements had annual revenue of 85.18B INR, down -9.15%. The Ramco Cements had revenue of 23.97B in the quarter ending March 31, 2025, a decrease of -10.49%.

Revenue
85.18B
Revenue Growth
-9.15%
P/S Ratio
3.19
Revenue / Employee
22.61M
Employees
3,767
Market Cap
272.00B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202585.18B-8.58B-9.15%
Mar 31, 202493.76B12.19B14.94%
Mar 31, 202381.57B21.54B35.87%
Mar 31, 202260.04B7.13B13.47%
Mar 31, 202152.91B-983.00M-1.82%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UltraTech Cement784.12B
Asian Paints338.41B
Grasim Industries1,484.78B
Vedanta1,513.36B
Pidilite Industries131.40B
Solar Industries India75.40B
Shree Cement192.83B
Jindal Steel497.65B
Revenue Rankings